In concentrated doses, semaglutide acts like the hormone glucagon-like peptide-1 (GLP-1), that reduces your appetite and makes you feel full when you eat
Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth
However, retatrutide remains an investigational medicine
As people are eating less, they want to make their calories count, and they also want to make sure they are getting their greens and their vitamins, so I predict continued growth in green supplements (+16.3% in the year to October 6, 2024) and more interest in multivitamins (-2.7% in the year to Oct 6, 2024, but that reflects an improvement vs the -7% decline in the year to Oct 8, 2023)
There are additional rare but serious side effects you should be aware of when taking GLP-1s, including: Severe abdominal cramping Significant pain during bowel movements Bloody stool Persistent vomiting These side effects could indicate an intestinal blockage or gastroparesis and you should discontinue your medication and seek medical advice immediately
GLP-1s are a specific type of medication first launched in 2005 for the treatment of type 2 diabetes